Table 1. Summary of effects on viability by the genetic interaction between dMLF and DREF.

	Genotype	Percentage
en-GAL4, UAS-dMLF/CyO	en-GAL4, UAS-dMLF/UAS-GFP	39%
X		(n=57)
UAS-GFP (II)	UAS-GFP/CyO	61%
en-GAL4, UAS-dMLF/CyO	en-GAL4, UAS-dMLF/UAS-DREF	0%
X		(n=40)
UAS-DREF (II)	UAS-DREF/CyO	100%
en-GAL4, UAS-dMLF/CyO	UAS-dref-IR/+ or y; en-GAL4, UAS-dMLF/+	0%
X		(n=81)
UAS-dref-IR (X) #10	UAS-dref-IR/+ or y; +/CyO	100%
en-GAL4/CyO	UAS-dref-IR/+ or y; en-GAL4	49%
X		(n=199)
UAS-dref-IR (X) #10	UAS-dref-IR/+ or y; +/CyO	51%
en-GAL4, UAS-dMLF/CyO	UAS-dref-IR/+ or y; en-GAL4, UAS-dMLF/+	0%
X		(n=38)
UAS-dref-IR (X) #15	UAS-dref-IR/+ or y; +/CyO	100%
en-GAL4/CyO	UAS-dref-IR/+ or y; en-GAL4	59%
X		(n=228)
UAS-dref-IR (X) #15	UAS-dref-IR/+ or y; +/CyO	41%

Abbreviations: dMLF, Drosophila myelodysplasia/myeloid leukemia factor; DREF, DNA replication-related element-binding factor.